Capricor Therapeutics Inc
Biotechnology
Healthcare
CAPR
33.00 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
8.51
52 week high
21.99
high
9.57
52 week low
3.56
low
8.11
growth
65.49 %
previous Close
8.70
P/E ratio
market cap
640 M
div yield
0
usd
Sep 2024
qoq
revenue
2.26 M
-43.05 %
net incoming
-12.56 M
-14.15 %
eps
0.00 %
-8.57 %
eps surprise
-5.56 %
net profit margin
-555.20 %
-278.00 %
operating incoming
-13.01 M
-12.24 %
net change in cash
57.69 M
1.00 %
cash on hand
68.38 M
539.74 %
cost of revenue
-2.26 B
-633.00 %
top top